These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23196000)
1. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss. Yeo YH; Byrne NP; Counelis GJ; Perry A Clin Neuropathol; 2013; 32(3):159-64. PubMed ID: 23196000 [TBL] [Abstract][Full Text] [Related]
2. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151 [TBL] [Abstract][Full Text] [Related]
3. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal mutational analysis of a cerebellar pilocytic astrocytoma recurring as a ganglioglioma. Fiset PO; Fontebasso AM; De Jay N; Gayden T; Nikbakht H; Majewski J; Jabado N; Albrecht S Pediatr Blood Cancer; 2017 Feb; 64(2):275-278. PubMed ID: 27718322 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma. Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915 [TBL] [Abstract][Full Text] [Related]
7. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552 [TBL] [Abstract][Full Text] [Related]
8. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations. Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883 [TBL] [Abstract][Full Text] [Related]
9. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767 [TBL] [Abstract][Full Text] [Related]
10. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. Ida CM; Lambert SR; Rodriguez FJ; Voss JS; Mc Cann BE; Seys AR; Halling KC; Collins VP; Giannini C J Neuropathol Exp Neurol; 2012 Jul; 71(7):631-9. PubMed ID: 22710963 [TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation. Kanamori M; Suzuki H; Takei H; Sonoda Y; Uenohara H; Tominaga T Brain Tumor Pathol; 2016 Jan; 33(1):50-6. PubMed ID: 26404554 [TBL] [Abstract][Full Text] [Related]
12. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior. Bannykh SI; Mirocha J; Nuno M; Lopategui J; Kandala G Clin Neuropathol; 2014; 33(6):388-98. PubMed ID: 25066317 [TBL] [Abstract][Full Text] [Related]
14. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study. Tihan T; Ersen A; Qaddoumi I; Sughayer MA; Tolunay S; Al-Hussaini M; Phillips J; Gupta N; Goldhoff P; Baneerjee A Am J Surg Pathol; 2012 Jan; 36(1):43-55. PubMed ID: 21989351 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530 [TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Rodriguez EF; Scheithauer BW; Giannini C; Rynearson A; Cen L; Hoesley B; Gilmer-Flynn H; Sarkaria JN; Jenkins S; Long J; Rodriguez FJ Acta Neuropathol; 2011 Mar; 121(3):407-20. PubMed ID: 21113787 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations. Murakami C; Yoshida Y; Yamazaki T; Yamazaki A; Nakata S; Hokama Y; Ishiuchi S; Akimoto J; Shishido-Hara Y; Yoshimoto Y; Matsumura N; Nobusawa S; Ikota H; Yokoo H Brain Tumor Pathol; 2019 Jul; 36(3):103-111. PubMed ID: 30972500 [TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia. Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422 [TBL] [Abstract][Full Text] [Related]
19. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry. Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918 [TBL] [Abstract][Full Text] [Related]